Zeng Xiao-feng

431 total citations
9 papers, 273 citations indexed

About

Zeng Xiao-feng is a scholar working on Epidemiology, Rheumatology and Surgery. According to data from OpenAlex, Zeng Xiao-feng has authored 9 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 4 papers in Rheumatology and 2 papers in Surgery. Recurrent topics in Zeng Xiao-feng's work include IgG4-Related and Inflammatory Diseases (2 papers), Gastrointestinal disorders and treatments (2 papers) and Systemic Lupus Erythematosus Research (2 papers). Zeng Xiao-feng is often cited by papers focused on IgG4-Related and Inflammatory Diseases (2 papers), Gastrointestinal disorders and treatments (2 papers) and Systemic Lupus Erythematosus Research (2 papers). Zeng Xiao-feng collaborates with scholars based in China and Thailand. Zeng Xiao-feng's co-authors include Fengchun Zhang, Panpan Zhang, Di Wu, Wen Zhang, Yan Zhao, Xuan Zhang, Nan Jiang, Yu Chen, Hua Chen and Qingjun Wu and has published in prestigious journals such as Scientific Reports, Medicine and Lara D. Veeken.

In The Last Decade

Zeng Xiao-feng

8 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zeng Xiao-feng China 5 205 141 123 41 37 9 273
Anke Rietveld Netherlands 7 144 0.7× 206 1.5× 40 0.3× 64 1.6× 97 2.6× 11 309
L. Bolko France 8 141 0.7× 173 1.2× 33 0.3× 84 2.0× 75 2.0× 20 320
Hiroshi Ogishima Japan 11 142 0.7× 39 0.3× 47 0.4× 44 1.1× 34 0.9× 22 223
Esthela Loyo United States 7 130 0.6× 102 0.7× 14 0.1× 21 0.5× 83 2.2× 9 268
Ammar Muhammad Netherlands 11 48 0.2× 83 0.6× 168 1.4× 26 0.6× 8 0.2× 26 395
Ilias Lazarou Switzerland 6 80 0.4× 68 0.5× 21 0.2× 19 0.5× 24 0.6× 22 154
Lilian Vasaitis Sweden 7 155 0.8× 81 0.6× 237 1.9× 46 1.1× 79 2.1× 9 479
Loïc Guillevin France 3 197 1.0× 55 0.4× 58 0.5× 59 1.4× 26 0.7× 4 399
LJ Jara Mexico 5 136 0.7× 25 0.2× 33 0.3× 15 0.4× 60 1.6× 11 252
Samar M. Fawzy Egypt 8 122 0.6× 24 0.2× 23 0.2× 21 0.5× 90 2.4× 24 210

Countries citing papers authored by Zeng Xiao-feng

Since Specialization
Citations

This map shows the geographic impact of Zeng Xiao-feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeng Xiao-feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeng Xiao-feng more than expected).

Fields of papers citing papers by Zeng Xiao-feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeng Xiao-feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeng Xiao-feng. The network helps show where Zeng Xiao-feng may publish in the future.

Co-authorship network of co-authors of Zeng Xiao-feng

This figure shows the co-authorship network connecting the top 25 collaborators of Zeng Xiao-feng. A scholar is included among the top collaborators of Zeng Xiao-feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeng Xiao-feng. Zeng Xiao-feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Li, Yueting, Qiao Lin, Yongfu Wang, et al.. (2024). Long‐term survival analysis of patients with primary Sjögren's syndrome in China: A multicenter retrospective cohort study. International Journal of Rheumatic Diseases. 27(9). e15284–e15284.
2.
Wu, Qingqing, Man Xu, Min Zhang, et al.. (2021). Activation of Toll‐like receptor 7 provides cardioprotection in septic cardiomyopathy‐induced systolic dysfunction. Clinical and Translational Medicine. 11(1). e266–e266. 29 indexed citations
3.
Peng, Yu, Panpan Zhang, Xia Zhang, et al.. (2018). Efficacy and safety of low dose Mycophenolate mofetil treatment for immunoglobulin G4-related disease: a randomized clinical trial. Lara D. Veeken. 58(1). 52–60. 90 indexed citations
4.
Chen, Yu, Panpan Zhang, Hua Chen, et al.. (2017). Efficacy of Cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids. Scientific Reports. 7(1). 6195–6195. 83 indexed citations
5.
Wang, Mingyu, et al.. (2015). Peripheral Neuropathies Due to Systemic Lupus Erythematosus in China. Medicine. 94(11). e625–e625. 42 indexed citations
6.
Jiang, Nan, et al.. (2014). Correlation of Th17 cells and CD4+CD25+ regulatory T cells with clinical parameters in patients with systemic sclerosis. Chinese Medical Journal. 127(20). 3557–3561. 24 indexed citations
7.
Xiao-feng, Zeng. (2011). Diagnosis and treatment of systemic sclerosis. 2 indexed citations
8.
Xiao-feng, Zeng. (2006). Advances in the research and the development of plant essential oils. Food Science and Technology International. 2 indexed citations
9.
Xiao-feng, Zeng. (2005). A new synthetic immunomodulator——pidotimod. Chinese New Drugs Journal. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026